Literature DB >> 17111080

Urological complications of congenital nephrogenic diabetes insipidus--long-term follow-up of one patient.

M Hora1, T Reischig, O Hes, J Ferda, J Klecka.   

Abstract

A male with a severe form of congenital nephrogenic diabetes insipidus (diuresis 10 l per day) had megaureters, megavesica, large residuum and a history of three traumatic ruptures of the megavesica and a recurrent urinary tract infection (RUTI). Hemodialysis was introduced at 41 years of age. At age of 42, he underwent a bilateral retroperitoneoscopic nephrectomy to prevent further RUTI and 8 months later transplantation of a cadaver kidney. Intermittent catheterization is necessary due to residual urine in the urinary bladder.

Entities:  

Mesh:

Year:  2006        PMID: 17111080     DOI: 10.1007/s11255-006-0093-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  3 in total

1.  Nonobstructive urinary tract dilatation in nephrogenic diabetes insipidus.

Authors:  T Nakada; T Miyauchi; H Sumiya; J Shimazaki
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus.

Authors:  A F van Lieburg; N V Knoers; L A Monnens
Journal:  J Am Soc Nephrol       Date:  1999-09       Impact factor: 10.121

3.  Congenital nephrogenic diabetes insipidus presented with bilateral hydronephrosis: genetic analysis of V2R gene mutations.

Authors:  Tae-Hyun Yoo; Dong-Ryeol Ryu; Young Soo Song; Sang Chul Lee; Hyung Jong Kim; Joo Seong Kim; Hoon Young Choi; Shin-Wook Kang
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

  3 in total
  5 in total

1.  Pre- and post-treatment urinary tract findings in children with nephrogenic diabetes insipidus.

Authors:  María Gracia Caletti; Alejandro Balestracci; Diana Di Pinto
Journal:  Pediatr Nephrol       Date:  2013-12-14       Impact factor: 3.714

2.  Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats.

Authors:  Anyi Wang; Takuo Hirose; Yusuke Ohsaki; Chika Takahashi; Emiko Sato; Ikuko Oba-Yabana; Satoshi Kinugasa; Yoshikazu Muroya; Sadayoshi Ito; Takefumi Mori
Journal:  Clin Exp Nephrol       Date:  2018-11-13       Impact factor: 2.801

3.  Nephrogenic diabetes insipidus : Old deletion, new effect. A case report of a family from Greece.

Authors:  D Tramma; S Kalamitsou
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

4.  Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients.

Authors:  Niek F Casteleijn; A Lianne Messchendorp; Kyong T Bae; Eiji Higashihara; Peter Kappert; Vicente Torres; Esther Meijer; Anna M Leliveld
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

5.  Functional and morphological alterations of the urinary bladder in type 2 diabetic FVB(db/db) mice.

Authors:  Liyang Wu; Xiaodong Zhang; Nan Xiao; Yexiang Huang; Michael Kavran; Rania A Elrashidy; Mingshuai Wang; Firouz Daneshgari; Guiming Liu
Journal:  J Diabetes Complications       Date:  2016-03-08       Impact factor: 2.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.